About JHU AVEG
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Institute of Allergy and Infectious Diseases (NIAID)
9
Clinical Trials at JHU AVEG
During the past decade, JHU AVEG conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Phase I Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160
1991-05-01
Completed
72
A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV Envelope Vaccine (HIVAC-1e) in Combination With a Panel of Subunit Recombinant HIV Envelope Vaccines
1994-07-01
Completed
56
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "JHU AVEG"
#1 collaborator was "Protein Sciences Corporation" with 2 trials as a collaborator, "Biocine" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "Immuno-US" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at JHU AVEG
According to Clinical.Site data, the most researched conditions in "JHU AVEG" are
"HIV Infections" (9 trials). Many other conditions were trialed in "JHU AVEG" in a lesser frequency.
Clinical Trials Intervention Types at JHU AVEG
Most popular intervention types in "JHU AVEG" are "Biological" (9 trials). Other intervention types were less common.
The name of intervention was led by "gp160 Vaccine (MicroGeneSys)" (3 trials), "rgp120/HIV-1 SF-2" (3 trials), "rgp120/HIV-1MN" (3 trials), "Aluminum hydroxide" (2 trials) and "QS-21" (2 trials). Other intervention names were less common.
Clinical Trials Genders at JHU AVEG
The vast majority of trials in "JHU AVEG" are
9 trials for "All" genders.
Clinical Trials Status at JHU AVEG
Currently, there are NaN active trials in "JHU AVEG".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 9 completed trials in JHU AVEG,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in JHU AVEG, 8 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".